Schulman KA - Search Results

1

Metaanalysis and review of heart failure disease management randomized controlled clinical trials.

Whellan DJ, Hasselblad V, Peterson E, O'Connor CM, Schulman KA. Whellan DJ, et al. Among authors: schulman ka. Am Heart J. 2005 Apr;149(4):722-9. doi: 10.1016/j.ahj.2004.09.023. Am Heart J. 2005. PMID: 15990759 Review.

2

Differences in care-seeking behavior for acute chest pain in the United States and Japan.

Liao L, Whellan DJ, Tabuchi K, Schulman KA. Liao L, et al. Among authors: schulman ka. Am Heart J. 2004 Apr;147(4):630-5. doi: 10.1016/j.ahj.2003.10.006. Am Heart J. 2004. PMID: 15077077

3

The Warfarin and Antiplatelet Therapy in Heart Failure trial (WATCH): rationale, design, and baseline patient characteristics.

Massie BM, Krol WF, Ammon SE, Armstrong PW, Cleland JG, Collins JF, Ezekowitz M, Jafri SM, O'Connor CM, Packer M, Schulman KA, Teo K, Warren S. Massie BM, et al. Among authors: schulman ka. J Card Fail. 2004 Apr;10(2):101-12. doi: 10.1016/j.cardfail.2004.02.006. J Card Fail. 2004. PMID: 15101020 Clinical Trial.

4

Multinational economic evaluation of valsartan in patients with chronic heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT).

Reed SD, Friedman JY, Velazquez EJ, Gnanasakthy A, Califf RM, Schulman KA. Reed SD, et al. Among authors: schulman ka. Am Heart J. 2004 Jul;148(1):122-8. doi: 10.1016/j.ahj.2003.12.040. Am Heart J. 2004. PMID: 15215801 Clinical Trial.

5

Reducing the costs of phase III cardiovascular clinical trials.

Eisenstein EL, Lemons PW 2nd, Tardiff BE, Schulman KA, Jolly MK, Califf RM. Eisenstein EL, et al. Among authors: schulman ka. Am Heart J. 2005 Mar;149(3):482-8. doi: 10.1016/j.ahj.2004.04.049. Am Heart J. 2005. PMID: 15864237

6

Resource use, costs, and quality of life among patients in the multinational Valsartan in Acute Myocardial Infarction Trial (VALIANT).

Reed SD, Radeva JI, Weinfurt KP, McMurray JJ, Pfeffer MA, Velazquez EJ, Allsbrook JS, Masselink LE, Sellers MA, Califf RM, Schulman KA; VALIANT Investigators. Reed SD, et al. Among authors: schulman ka. Am Heart J. 2005 Aug;150(2):323-9. doi: 10.1016/j.ahj.2004.08.037. Am Heart J. 2005. PMID: 16086938 Clinical Trial.

7

Costs for heart failure with normal vs reduced ejection fraction.

Liao L, Jollis JG, Anstrom KJ, Whellan DJ, Kitzman DW, Aurigemma GP, Mark DB, Schulman KA, Gottdiener JS. Liao L, et al. Among authors: schulman ka. Arch Intern Med. 2006 Jan 9;166(1):112-8. doi: 10.1001/archinte.166.1.112. Arch Intern Med. 2006. PMID: 16401819

8

Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation.

Eisenstein EL, Anstrom KJ, Kong DF, Shaw LK, Tuttle RH, Mark DB, Kramer JM, Harrington RA, Matchar DB, Kandzari DE, Peterson ED, Schulman KA, Califf RM. Eisenstein EL, et al. Among authors: schulman ka. JAMA. 2007 Jan 10;297(2):159-68. doi: 10.1001/jama.297.2.joc60179. Epub 2006 Dec 5. JAMA. 2007. PMID: 17148711

9

Curbing the cardiovascular disease epidemic: aligning industry, government, payers, and academics.

Califf RM, Harrington RA, Madre LK, Peterson ED, Roth D, Schulman KA. Califf RM, et al. Among authors: schulman ka. Health Aff (Millwood). 2007 Jan-Feb;26(1):62-74. doi: 10.1377/hlthaff.26.1.62. Health Aff (Millwood). 2007. PMID: 17211015

10

Financial implications of a model heart failure disease management program for providers, hospital, healthcare systems, and payer perspectives.

Whellan DJ, Reed SD, Liao L, Gould SD, O'connor CM, Schulman KA. Whellan DJ, et al. Among authors: schulman ka. Am J Cardiol. 2007 Jan 15;99(2):256-60. doi: 10.1016/j.amjcard.2006.08.019. Epub 2006 Nov 27. Am J Cardiol. 2007. PMID: 17223429

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

417 results

Search Page